InspireMD, Inc. Receives Nasdaq Notice of Non-Compliance with Minimum Bid Price Requirement
Key Points from the Report
- Nasdaq Listing Rule Violation: InspireMD, Inc. (NASDAQ: NSPR) has received a formal notice from The Nasdaq Capital Market stating that the company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed companies to maintain a minimum closing bid price of \$1.00 per share.
- Non-Compliance Period: The notice was issued after the company’s common stock failed to meet the minimum bid price requirement for 30 consecutive business days, from June 3, 2026, through July 16, 2026.
- No Immediate Delisting: The notice does not have an immediate effect on the listing or trading of InspireMD’s common stock. The shares will continue to trade on The Nasdaq Capital Market under the ticker symbol “NSPR.”
- Compliance Period Provided: In accordance with Nasdaq Listing Rule 5810(c)(3)(A), InspireMD has been granted an 180-calendar-day compliance period, until January 13, 2027, to regain compliance.
- Regaining Compliance: To comply, the company’s closing bid price must meet or exceed \$1.00 per share for at least 10 consecutive business days during the compliance period. Nasdaq may, at its discretion, require the minimum price be maintained for a longer period to demonstrate long-term compliance.
- Potential for Further Action: If the company does not regain compliance by January 13, 2027, but meets all other initial listing standards (excluding the bid price) and notifies Nasdaq in writing of its intention to cure the deficiency (potentially via a reverse stock split), InspireMD may be eligible for a second 180-day compliance period.
- Risk of Delisting: If the company cannot cure the deficiency or is deemed ineligible for an additional compliance period, Nasdaq may initiate delisting proceedings. InspireMD would have the right to appeal this decision to a Nasdaq Hearings Panel.
- Management Response: InspireMD intends to closely monitor its stock price and consider all available options, including a reverse stock split, to regain compliance. However, there is no assurance that the company will be able to regain compliance within the provided time frame or maintain compliance with other Nasdaq listing requirements.
Important Information for Shareholders
- Potential Share Price Impact: The failure to meet Nasdaq’s minimum bid price requirement is a significant event that may affect shareholder value. The risk of delisting could impact liquidity and decrease investor confidence, leading to downward pressure on the stock price.
- Reverse Stock Split Possibility: Management has indicated that a reverse stock split is one of the options under consideration to regain compliance. While such corporate actions may help the company meet the minimum price requirement, they often have mixed effects on share value and market sentiment.
- Ongoing Trading on Nasdaq: For now, InspireMD shares will continue to trade as usual on The Nasdaq Capital Market under the ticker “NSPR.”
- No Current Change in Business Operations: The notice from Nasdaq does not impact the company’s day-to-day operations or its business strategy at this stage.
- Future Outlook Uncertain: There is no guarantee that InspireMD will successfully regain compliance or avoid delisting, and shareholders should carefully monitor future company announcements and developments.
Additional Details
- Date of Reported Event: July 17, 2026
- Exchange & Ticker: Nasdaq Capital Market, NSPR
- Security: Common Stock, \$0.0001 par value per share
- Company Headquarters: 6303 Waterford District Drive, Suite 215, Miami, FL 33126
- Company Contact: (888) 776-6804
- Emerging Growth Company Status: InspireMD is not classified as an emerging growth company.
What Investors Should Watch
- Monitor InspireMD’s share price and volume closely over the coming months for signs of recovery or further decline.
- Look for any official announcements regarding corporate actions, such as a potential reverse stock split or other measures to regain compliance.
- Stay updated on any communications from Nasdaq regarding the company’s compliance status.
- Be aware of the risk of delisting, which could impact the ability to trade shares on a major exchange and may reduce liquidity.
Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. The author and publisher are not responsible for any losses arising from reliance on the information provided above.
